Skip to content
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO

    North America

    Canada

    United States of America

    Latin AMerica

    Brazil

    Mexico

    Europe

    European Union

    Australia

    Australia

    Asia

    China

    Japan

    South Korea

    Taiwan

    Singapore

    India

  • Services

    Medical Devices

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Strategy
    • Regulatory Affairs
    • Product Registration
    • Medical Writing
    • Health Authority Consultation
    • Clinical

    Pharmaceuticals

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Strategy
    • Regulatory Affairs
    • Product Registration
    • Regulatory Operations
    • Health Authority Consultation

    Nutraceuticals / Food Supplements

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Affairs
    • Regulatory Strategy
    • Verification of Nutrient Claims
    • Verification of Health Claims

    Cosmetics & Personal Care Products

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Affairs
    • Regulatory Strategy
    • Cosmetic Packaging and Labeling Review
    • Product Classification and Formulation Review

    Pharmacovigilance

    • Overview
    • GRP Pharmacoviglance Services

    Quality

    • Preparation for FDA Inspections
    • GMP Mockup Quality Audits
    • ISO 13485 Quality Audits
    • GCP Audits
    • cGTP Audits
    • GAP Analysis Audits
    • Foreign Manufacture Accreditation (FMA)
    • QA SOPs Development
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)

    Japan

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    China

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    Brazil

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    Mexico

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    USA

    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements
  • Contact Us
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO
  • Services
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)
  • Contact Us
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO
  • Services
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)
  • Contact Us
Home / Products / Page 7

Showing 97–112 of 155 results

  • PFSB No. 1121-15:  Applications for Marketing Approval of In Vitro Diagnostics

    PFSB No. 1121-15: Applications for Marketing Approval of In Vitro Diagnostics

    $50.00
    Add to cart
  • Sale! PFSB-ELD No. 0404-1: Guideline on Data Monitoring Committee

    PFSB-ELD No. 0404-1: Guideline on Data Monitoring Committee

    $15.00 Original price was: $15.00.$14.00Current price is: $14.00.
    Add to cart
  • PFSB/ELD Notification No. 0527-1,2010 Vaccines Against the Novel Coronavirus SARS-CoV-2

    PFSB/ELD Notification No. 0527-1,2010 Vaccines Against the Novel Coronavirus SARS-CoV-2

    $30.00
    Add to cart
  • PFSB/ELD Notification No. 0611-1 June 11, 2012  Guideline for Clinical Evaluation of Diagnostic Radiopharmaceuticals

    PFSB/ELD Notification No. 0611-1 June 11, 2012 Guideline for Clinical Evaluation of Diagnostic Radiopharmaceuticals

    $50.00
    Add to cart
  • PFSB/ELD Notification No. 1228-7 Basic Principles of Risk-based Monitoring

    PFSB/ELD Notification No. 1228-7 Basic Principles of Risk-based Monitoring

    $100.00
    Add to cart
  • PMDA Guideline:  Master File System for Drug Substances (MF) in Japan

    PMDA Guideline: Master File System for Drug Substances (MF) in Japan

    $30.00
    Add to cart
  • PMDA Guideline: Application for Accreditation of Foreign Manufacturers (FMA) to PMDA in Japan

    PMDA Guideline: Application for Accreditation of Foreign Manufacturers (FMA) to PMDA in Japan

    $30.00
    Add to cart
  • PMDA Guideline: Conditional Early Approval System for Innovative Medical Device Products (Fast-Break Scheme) in Japan

    PMDA Guideline: Conditional Early Approval System for Innovative Medical Device Products (Fast-Break Scheme) in Japan

    $50.00
    Add to cart
  • PMDA Guideline: Cosmetic Standards in Japan

    PMDA Guideline: Cosmetic Standards in Japan

    $20.00
    Add to cart
  • PMDA Guideline: List of Active Ingredients in Medicinal Cosmetics in Japan

    PMDA Guideline: List of Active Ingredients in Medicinal Cosmetics in Japan

    $50.00
    Add to cart
  • PMDA Guideline: Nanotechnology Cosmetic in Japan

    PMDA Guideline: Nanotechnology Cosmetic in Japan

    $20.00
    Add to cart
  • PMDA Guidelines: Clinical Study Data on Medical Devices from Foreign Clinical Studies in Japan

    PMDA Guidelines: Clinical Study Data on Medical Devices from Foreign Clinical Studies in Japan

    $30.00
    Add to cart
  • PMDA Guidline: Applications for Marketing Approval related to the Handling of Medical Device Software in Japan

    PMDA Guidline: Applications for Marketing Approval related to the Handling of Medical Device Software in Japan

    $15.00
    Add to cart
  • PMDA Notification No.171/2004: Procedures for Developing Post-marketing Study Plan

    PMDA Notification No.171/2004: Procedures for Developing Post-marketing Study Plan

    $30.00
    Add to cart
  • PMDA PFSB/ELD Notification No.899/2001: Points to Consider for Reducing Total Review Time for New Drug Applications

    PMDA PFSB/ELD Notification No.899/2001: Points to Consider for Reducing Total Review Time for New Drug Applications

    $30.00
    Add to cart
  • PMDA-CPE No.1116002: Procedure for Remote Inspection for Drugs & Regenerative Products

    PMDA-CPE No.1116002: Procedure for Remote Inspection for Drugs & Regenerative Products

    $30.00
    Add to cart
  • ←
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • →

ABOUT GRP GROUP

  • About US
  • Leadership
  • Why Choose Us

Useful Links

  • Contact Us
  • Brochures
  • Resource Center

GRP Headquarters (USA)

303 Wyman Street, Suite 300
Waltham, MA. 02451, USA
Tel : (+1 ) 781 - 672 -4200
Info@globalregulatorypartners.com

GRP Group Offices

  • GRP USA
  • GRP Japan
  • GRP China
  • GRP Korea
  • GRP Brazil
  • GRP Mexico

Follow Us on Social Media

Twitter Youtube Linkedin
  • Privacy Policy
  • Terms & Conditions
  • Cookies Policy
  • Other Policies

Copyright ©2023 Global Regulatory Partners

Contact Us!